USFDA bans imports from Ipca Labs' Ratlam plant

Ipca had voluntarily halted shipments to the US from the plant in July last year

The US Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Ipca Laboratories Ltd's plant at Ratlam in Madhya Pradesh due to violations of standard production practices.

Ipca had voluntarily halted shipments to the United States from the plant in July last year after the FDA outlined half a dozen violations including data integrity issues.

The FDA announced the ban, called import alert, in a notice on its website late on Thursday. It did not elaborate.

Over the past year, large Indian drugmakers such as Ranbaxy Laboratories Ltd and Wockhardt Ltd have been hit by a spate of regulatory sanctions due to concerns about production processes at their local plants.

Ipca shares were down 3.8% at Rs 672.40 in morning trade on Friday, while the Nifty was up 1.1%.

($1 = 61.4300 rupees)